Boston Scientific's 3-D navigation system for cardiac mapping has received 510(k) clearance from the FDA. The Rhythmia Mapping system aims to make electrophysiology procedures and catheter ablations ...
Boston Scientific Corp. (BSX) reported that it has come to terms to buy privately-held Rhythmia Medical Inc., a maker of mapping and navigation systems used in heart surgeries, for up to $265 million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results